ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,162Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 288

$362K Total Retail Price of All Prescriptions

Rank: 138 out of 288

430 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 430 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 374 355 1 3
HYDROCODONE-ACETAMINOPHEN 318 301 S3 2 7
SIMVASTATIN 299 277 3 1
LEVOTHYROXINE SODIUM 278 263 4 2
LISINOPRIL 264 263 5 4
AMLODIPINE BESYLATE 251 245 6 6
ZOLPIDEM TARTRATE 206 205 7 22
FUROSEMIDE 194 185 8 5
CITALOPRAM HBR 164 157 9 18
GABAPENTIN 144 144 10 17
METFORMIN HCL 127 123 11 12
POTASSIUM CHLORIDE 127 115 11 11
DONEPEZIL HCL 124 124 13 29
ATENOLOL 111 103 14 10
TRAZODONE HCL 110 102 15 37
ATORVASTATIN CALCIUM 108 99 16 14
FENTANYL 105 104 S2 17 57
CARVEDILOL 100 92 18 27
DOXAZOSIN MESYLATE 100 100 18 78
LOSARTAN POTASSIUM 96 96 20 16
WARFARIN SODIUM 92 92 21 9
POLYETHYLENE GLYCOL 3350 88 79 22 38
NAMENDA 80 80 23 39
BENAZEPRIL HCL 80 80 23 52
PRAVASTATIN SODIUM 79 74 25 21
TAMSULOSIN HCL 76 76 26 24
TRAMADOL HCL 76 75 26 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 76 26 34
LOVASTATIN 74 74 29 46
CYMBALTA 74 73 29 67
MORPHINE SULFATE ER 72 71 S2 31 131
ISOSORBIDE MONONITRATE ER 71 65 32 35
HYDROCHLOROTHIAZIDE 69 67 33 13
OXYBUTYNIN CHLORIDE 62 62 34 69
METOPROLOL TARTRATE 61 61 35 8
LANTUS 59 51 36 31
LABETALOL HCL 59 59 36 147
LYRICA 58 45 38 114
SERTRALINE HCL 58 56 38 25
GLIMEPIRIDE 53 52 40 32
MIRTAZAPINE 51 51 41 60
PREDNISONE 51 40 41 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.